Table 2.
Baseline characteristics in non-diabetic patients with STEMI based on ABG levels
| ABG (mmol/L) | p | ||
|---|---|---|---|
| ≤7.80 | >7.80 | ||
| n | 170 | 86 | |
| Patient demographics | |||
| Age (years) | 60 (36–79) | 64 (44–72) | 0.011 |
| Males | 105 (61.8) | 50 (58.1) | 0.590 |
| BMI (kg/m2) | 26.6 (23.5–41.9) | 26.6 (20.3–32.7) | 0.233 |
| Medical history | |||
| Prior MI | 18 (10.6) | 12 (14.0) | 0.420 |
| Prior PCI | 27 (15.9) | 13 (15.1) | 1.000 |
| Prior CABG | 11 (6.5) | 6 (7.0) | 1.000 |
| Risk factors | |||
| Hypertension | 114 (67.1) | 59 (68.6) | 0.888 |
| Hyperlipidemia | 92 (54.1) | 49 (57.0) | 0.692 |
| Current smoking | 88 (51.8) | 41 (47.7) | 0.597 |
| LVEF (%) | 55.81 ± 10.34 | 51.57 ± 9.80 | 0.017 |
| eGFR (mL/min/1.73 m2) | 73.54 ± 28.54 | 58.85 ± 16.86 | <0.001 |
| TC (mmol/L) | 4.58 ± 0.96 | 4.71 ± 0.95 | 0.287 |
| TG (mmol/L) | 1.81 ± 1.39 | 1.93 ± 0.75 | 0.376 |
| ABG (mmol/L) | 6.17 ± 1.07 | 9.56 ± 1.27 | <0.001 |
| MAGE (mmol/L) | 2.62 ± 1.15 | 3.40 ± 1.45 | <0.001 |
| HbA1c (%) | 4.76 ± 1.28 | 5.81 ± 1.42 | <0.001 |
| Angiographic data | |||
| Culprit vessel, LAD | 65 (38.2) | 41 (47.7) | 0.179 |
| Multi-vessel CAD | 82 (48.2) | 49 (57.0) | 0.233 |
| TIMI grade 3 before PCI | 43 (25.3) | 18 (20.9) | 0.535 |
| TIMI grade 3 after PCI | 162 (95.3) | 79 (91.9) | 0.273 |
| Stents | 1.54 ± 0.911 | 1.72 ± 1.04 | 0.170 |
Data are mean ± SD and number (%)
STEMI ST elevated myocardial infarction, ABG admission blood glucose, BMI body mass index, MI myocardial infarction, PCI percutaneous coronary intervention, CABG coronary artery bypass graft, LVEF left ventricular ejection fraction, eGFR estimated glomerular filtration rate, TC total cholesterol, TG triglyceride, MAGE the mean amplitude of glycemic excursions, HbA 1c glycated hemoglobin, LAD left anterior descending artery, CAD coronary artery disease